| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |